DK3438096T3 - Fremgangsmåde til fremstilling af 1-(arylmethyl)quinazolin-2,4-(1H, 3H)-dioner - Google Patents

Fremgangsmåde til fremstilling af 1-(arylmethyl)quinazolin-2,4-(1H, 3H)-dioner Download PDF

Info

Publication number
DK3438096T3
DK3438096T3 DK17773281.5T DK17773281T DK3438096T3 DK 3438096 T3 DK3438096 T3 DK 3438096T3 DK 17773281 T DK17773281 T DK 17773281T DK 3438096 T3 DK3438096 T3 DK 3438096T3
Authority
DK
Denmark
Prior art keywords
arylmethyl
diones
quinazoline
preparation
Prior art date
Application number
DK17773281.5T
Other languages
English (en)
Inventor
Suixiong Cai
Ping Huang
Original Assignee
Impact Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Impact Therapeutics Inc filed Critical Impact Therapeutics Inc
Application granted granted Critical
Publication of DK3438096T3 publication Critical patent/DK3438096T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96—Two oxygen atoms
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/005—Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK17773281.5T 2016-04-01 2017-03-31 Fremgangsmåde til fremstilling af 1-(arylmethyl)quinazolin-2,4-(1H, 3H)-dioner DK3438096T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201610202881 2016-04-01
PCT/CN2017/078913 WO2017167251A1 (zh) 2016-04-01 2017-03-31 1-(芳基甲基)喹唑啉-2,4(1h,3h)-二酮的制备工艺

Publications (1)

Publication Number Publication Date
DK3438096T3 true DK3438096T3 (da) 2021-02-22

Family

ID=59963547

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17773281.5T DK3438096T3 (da) 2016-04-01 2017-03-31 Fremgangsmåde til fremstilling af 1-(arylmethyl)quinazolin-2,4-(1H, 3H)-dioner

Country Status (13)

Country Link
US (1) US10562889B2 (da)
EP (1) EP3438096B1 (da)
CN (1) CN109153652B (da)
CY (1) CY1123898T1 (da)
DK (1) DK3438096T3 (da)
ES (1) ES2859460T3 (da)
HR (1) HRP20210328T1 (da)
HU (1) HUE053554T2 (da)
PL (1) PL3438096T3 (da)
PT (1) PT3438096T (da)
RS (1) RS61556B1 (da)
SI (1) SI3438096T1 (da)
WO (1) WO2017167251A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230263801A1 (en) * 2020-07-24 2023-08-24 Impact Therapeutics (Shanghai), Inc Combination therapy of parp inhibitors
WO2022099442A1 (zh) * 2020-11-10 2022-05-19 上海瑛派药业有限公司 5-氟-1-(4-氟-3-(4-(嘧啶-2-基)哌嗪-1-羰基)苄基)喹唑啉-2,4(1h,3h)-二酮的结晶形式及其制备

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1611109A4 (en) * 2003-03-31 2009-06-24 Taisho Pharmaceutical Co Ltd NOVEL QUINAZOLINE DERIVATIVES AND THEIR THERAPEUTIC USE
CN1980913B (zh) * 2004-06-30 2011-12-14 詹森药业有限公司 作为parp抑制剂的喹唑啉二酮衍生物
NZ589252A (en) * 2004-09-02 2012-06-29 Vertex Pharma Quinazolines useful as inhibitors of voltage-gated sodium channels
CN101475537A (zh) * 2009-01-07 2009-07-08 太仓市浦源化工有限公司 一种2,4-二氯喹唑啉的制备方法
US9090568B2 (en) * 2011-03-14 2015-07-28 Impact Therapeutics, Inc. Quinazolinediones and their use
TWI527800B (zh) * 2011-04-01 2016-04-01 南京英派藥業有限公司 作為聚（二磷酸腺苷酸－核醣）聚合酶（ｐａｒｐ）之抑制劑之１－（芳基甲基）喹唑啉－２，４（１ｈ，３ｈ）－二酮及其應用
WO2013064083A1 (en) * 2011-11-01 2013-05-10 Impact Therapeutics, Inc. 1-(arylmethyl)-5,6,7,8-tetrahydroquinazoline-2,4-diones and analogs and the use thereof
US11179392B2 (en) * 2015-04-03 2021-11-23 Impact Therapeutics, Inc. Solid pharmaceutical formulation of PARP inhibitors and use thereof
WO2017109722A1 (en) * 2015-12-21 2017-06-29 Idemitsu Kosan Co., Ltd. Nitrogen-containing heterocyclic compounds and organic electroluminescence devices containing them

Also Published As

Publication number Publication date
EP3438096A4 (en) 2019-08-21
EP3438096A1 (en) 2019-02-06
ES2859460T3 (es) 2021-10-04
PT3438096T (pt) 2021-03-03
US20190112298A1 (en) 2019-04-18
US10562889B2 (en) 2020-02-18
PL3438096T3 (pl) 2021-05-17
EP3438096B1 (en) 2020-12-02
SI3438096T1 (sl) 2021-04-30
CN109153652B (zh) 2021-07-27
RS61556B1 (sr) 2021-04-29
CY1123898T1 (el) 2022-05-27
HRP20210328T1 (hr) 2021-04-02
WO2017167251A1 (zh) 2017-10-05
HUE053554T2 (hu) 2021-07-28
CN109153652A (zh) 2019-01-04

Similar Documents

Publication Publication Date Title
MA51771A (fr) Procédés de préparation de (1-(3-fluoro-2-(trifluorométhyl)isonicotinyl)pipéridine-4-one)
DK3509811T3 (da) Fremgangsmåde til fremstilling af polyolefin-recyklater
ZA201801534B (en) New uses of 2-(2,4-dichlorophenyl)methyl-4,4-dimethyl-3-isoxazolidone as foliar herbicide
DK3521282T3 (da) Quinazolinderivater anvendt til behandling af hiv
EP3246328A4 (en) Quinazoline heterocyclic compound as egfr kinase inhibitor, and preparation and application thereof
ZA201807179B (en) Pyrimidine compounds as jak kinase inhibitors
DK3293165T3 (da) Fremgangsmåde til fremstilling af gødningsgranulat, gødningsgranulat
DK3488028T3 (da) Fremgangsmåde til elektrokemisk fremstilling af ammoniak
DK3507408T3 (da) Fremgangsmåde til fremstilling af nonwoven
DK3377201T3 (da) Fremgangsmåde til fremstilling af membraner
DK3390354T3 (da) Fremgangsmåde til tilvejebringelse af carbondioxid til syntese af urea
DK3460102T3 (da) Fremgangsmåde til fremstilling af en elektrokatalysator
DK3094178T3 (da) Agrokemisk sammensætning, der omfatter n,n'-diphenyl(thio)urea til forbedring af afgrødeproduktivitet
DK3251523T3 (da) Fremgangsmåde til fremstilling af granuleret tilskudsfoder
DK3114235T3 (da) Fremgangsmåde til bestemmelse af risiko for 5-fluorouracil-toksicitet
EP3448852A4 (en) NOVEL HETEROCYCLIC COMPOUNDS AS INHIBITORS OF TYROSINE KINASE BCR-ABL
DK3458467T3 (da) Fremgangsmåde til 6,7-alfa-epoxidering af steroid-4,6-diener
DK3297631T3 (da) NK-1/NK-3-receptorantagonist til behandling af hedeture
DK3408015T3 (da) Fremgangsmåde til fremstilling af emulsioner
DK3665204T3 (da) Fremgangsmåde til fremstilling af inhiberet stivelse.
DK3765440T3 (da) Fremgangsmåde til fremstilling af n-alkyl-nitratoethylnitraminer
DK3717476T3 (da) Fremgangsmåde til fremstilling af 2-(5-methoxyisochroman-1-yl)-4,5-dihydro-1H-imidazol og hydrogensulfatsaltet deraf
DK3507282T3 (da) Fremgangsmåde til fremstilling af indolcarboxamidforbindelser
DK3438096T3 (da) Fremgangsmåde til fremstilling af 1-(arylmethyl)quinazolin-2,4-(1H, 3H)-dioner
DK3443110T3 (da) Fermenteringsproces til fremstilling af maltosyl-isomalto-oligosaccharider (mimo)